Global biopharmaceutical firms Santen and Sydnexis entered an exclusive licensing deal for a drug formulation that aims to treat progressive myopia.

Johnson & Johnson Innovation kick started 2018 by striking collaborative agreements with 15 different organizations and companies to address areas of high unmet medical need in neuroscience, oncology and other areas.

Kids who spend more time outdoors and who play sports are less likely to be near-sighted, according to a recent study in a large, diverse group of urban 6-year-olds.